Related Experiment Video
Updated: Mar 6, 2026

06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
975
Reply to 'Comment on 'Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with
Takeo Fujii1,2, Naoto T Ueno1
1Department of Breast Medical Oncology, Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
British Journal of Cancer
|March 15, 2017
Abstract
No abstract available in PubMed .

